Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1414)
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
425
Price
$25.91
Total Value
$11.01K
Shares Held After
17,413
% of Holdings
2.4%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
1,969
Price
$24.84
Total Value
$48.91K
Shares Held After
16,988
% of Holdings
11.6%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
6,836
Price
$24.12
Total Value
$164.88K
Shares Held After
15,019
% of Holdings
45.5%
Nuvation Bio Inc. (NUVB)
Wentworth Kerry — CHIEF REGULATORY OFFICER
Shares
63,000
Price
$6.02
Total Value
$379.19K
Shares Held After
53,000
% of Holdings
54.3%
Nuvation Bio Inc. (NUVB)
Sauvage Philippe — Chief Financial Officer
Shares
47,668
Price
$6.01
Total Value
$286.37K
Shares Held After
12,673
% of Holdings
79.0%
BioCardia, Inc. (BCDA)
STERTZER SIMON H — Director
Shares
39,000
Price
$1.00
Total Value
$39.00K
Shares Held After
166,338
% of Holdings
23.4%
BridgeBio Pharma, Inc. (BBIO)
Cook Jennifer E. — Director
Shares
2,196
Price
$68.57
Total Value
$150.58K
Shares Held After
8,383
% of Holdings
20.8%
Arcus Biosciences, Inc. (RCUS)
Jaen Juan C. — President
Shares
1,697
Price
$28.06
Total Value
$47.62K
Shares Held After
897,240
% of Holdings
0.2%
Arcus Biosciences, Inc. (RCUS)
Jaen Juan C. — President
Shares
14,067
Price
$27.69
Total Value
$389.48K
Shares Held After
898,937
% of Holdings
1.5%
BridgeBio Pharma, Inc. (BBIO)
Valantine Hannah — Director
Shares
2,196
Price
$68.57
Total Value
$150.58K
Shares Held After
9,259
% of Holdings
19.2%
Cadrenal Therapeutics, Inc. (CVKD)
Pham Quang X — Director
Shares
2,277
Price
$3.20
Total Value
$7.29K
Shares Held After
117,145
% of Holdings
1.9%
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
88
Price
$38.43
Total Value
$3.38K
Shares Held After
198,244
% of Holdings
0.0%
Vera Therapeutics, Inc. (VERA)
Fordyce Marshall — Director
Shares
18,412
Price
$37.93
Total Value
$698.39K
Shares Held After
198,332
% of Holdings
8.5%
Immuneering Corp (IMRX)
Zeskind Benjamin J. — Director
Shares
2,400
Price
$4.56
Total Value
$10.95K
Shares Held After
2,315,252
% of Holdings
0.1%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
1,657
Price
$21.47
Total Value
$35.58K
Shares Held After
3,848,256
% of Holdings
0.0%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
71,629
Price
$21.04
Total Value
$1.51M
Shares Held After
3,849,913
% of Holdings
1.8%
Maze Therapeutics, Inc. (MAZE)
Coloma Jason V — Director
Shares
23,865
Price
$26.05
Total Value
$621.67K
Shares Held After
319,079
% of Holdings
7.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,227
Price
$546.00
Total Value
$669.94K
Shares Held After
40,513
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,407
Price
$545.19
Total Value
$1.86M
Shares Held After
41,740
% of Holdings
7.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,329
Price
$544.29
Total Value
$723.36K
Shares Held After
45,147
% of Holdings
2.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
900
Price
$543.10
Total Value
$488.79K
Shares Held After
46,476
% of Holdings
1.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,444
Price
$542.13
Total Value
$782.83K
Shares Held After
47,376
% of Holdings
3.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
894
Price
$540.99
Total Value
$483.64K
Shares Held After
48,820
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
299
Price
$540.24
Total Value
$161.53K
Shares Held After
49,714
% of Holdings
0.6%
Spyre Therapeutics, Inc. (SYRE)
Fairmount Funds Management LLC — Director
Shares
4,684,781
Price
$85.31
Total Value
$399.66M
Shares Held After
0
% of Holdings
100.0%
CYTOKINETICS INC (CYTK)
Malik Fady Ibraham — EVP Research & Development
Shares
3,500
Price
$79.51
Total Value
$278.29K
Shares Held After
153,902
% of Holdings
2.2%
Quantum-Si Inc (QSI)
Keyes Jeffry R. — Chief Financial Officer
Shares
4,116
Price
$0.96
Total Value
$3.94K
Shares Held After
1,728,466
% of Holdings
0.2%
Quantum-Si Inc (QSI)
Vieceli John S. — Chief Product Officer
Shares
15,111
Price
$0.96
Total Value
$14.47K
Shares Held After
1,155,546
% of Holdings
1.3%
Disc Medicine, Inc. (IRON)
Yu Jonathan Yen-Wen — Chief Operating Officer
Shares
9,700
Price
$72.66
Total Value
$704.80K
Shares Held After
54,324
% of Holdings
15.2%
Quantum-Si Inc (QSI)
Hawkins Jeffrey Alan — Director
Shares
11,310
Price
$0.96
Total Value
$10.83K
Shares Held After
3,681,113
% of Holdings
0.3%
Quantum-Si Inc (QSI)
LaPointe Christian — GC & Corp. Secretary
Shares
7,794
Price
$0.96
Total Value
$7.46K
Shares Held After
1,190,223
% of Holdings
0.7%
Oncotelic Therapeutics, Inc. (OTLC)
Trieu Vuong — Director
Shares
65,000
Price
$0.04
Total Value
$2.92K
Shares Held After
93,694,319
% of Holdings
0.1%
CAPRICOR THERAPEUTICS, INC. (CAPR)
Bergmann Anthony — CHIEF FINANCIAL OFFICER
Shares
500
Price
$30.00
Total Value
$15.00K
Shares Held After
11,223
% of Holdings
4.3%
CAPRICOR THERAPEUTICS, INC. (CAPR)
Krasney Karen — EVP, GENERAL COUNSEL
Shares
500
Price
$30.00
Total Value
$15.00K
Shares Held After
30,547
% of Holdings
1.6%
Apogee Therapeutics, Inc. (APGE)
HENDERSON MICHAEL THOMAS — Director
Shares
80,000
Price
$132.54
Total Value
$10.60M
Shares Held After
1,015,987
% of Holdings
7.3%
Apogee Therapeutics, Inc. (APGE)
Dambkowski Carl — Chief Medical Officer
Shares
26,400
Price
$132.60
Total Value
$3.50M
Shares Held After
179,248
% of Holdings
12.8%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
580
Price
$13.95
Total Value
$8.09K
Shares Held After
194,075
% of Holdings
0.3%
Korro Bio, Inc. (KRRO)
FORMELA JEAN FRANCOIS — Director
Shares
3,382
Price
$13.95
Total Value
$47.18K
Shares Held After
936,252
% of Holdings
0.4%
OnKure Therapeutics, Inc. (OKUR)
Leverone Jason A. — Chief Financial Officer
Shares
303
Price
$4.40
Total Value
$1.33K
Shares Held After
18,802
% of Holdings
1.6%
OnKure Therapeutics, Inc. (OKUR)
Saccomano Nicholas A — Director
Shares
86
Price
$4.40
Total Value
$378.08
Shares Held After
11,247
% of Holdings
0.8%
Septerna, Inc. (SEPN)
Long Daniel D. — SVP, Drug Discovery
Shares
7,000
Price
$35.97
Total Value
$251.78K
Shares Held After
96,412
% of Holdings
6.8%
Septerna, Inc. (SEPN)
Long Daniel D. — SVP, Drug Discovery
Shares
8,000
Price
$35.10
Total Value
$280.80K
Shares Held After
103,412
% of Holdings
7.2%
Enliven Therapeutics, Inc. (ELVN)
ORBIMED ADVISORS LLC — 10% Owner
Shares
46,776
Price
$45.00
Total Value
$2.10M
Shares Held After
6,555,102
% of Holdings
0.7%
Enliven Therapeutics, Inc. (ELVN)
ORBIMED ADVISORS LLC — 10% Owner
Shares
787,024
Price
$45.38
Total Value
$35.72M
Shares Held After
6,601,878
% of Holdings
10.7%
Enliven Therapeutics, Inc. (ELVN)
ORBIMED ADVISORS LLC — 10% Owner
Shares
1,477
Price
$45.00
Total Value
$66.47K
Shares Held After
219,405
% of Holdings
0.7%
Enliven Therapeutics, Inc. (ELVN)
ORBIMED ADVISORS LLC — 10% Owner
Shares
24,846
Price
$45.38
Total Value
$1.13M
Shares Held After
220,882
% of Holdings
10.1%
Faeth Therapeutics, Inc. (FTH)
Parikh Anand Kiran — Director
Shares
2,806
Price
$19.76
Total Value
$55.45K
Shares Held After
764,234
% of Holdings
0.4%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
356
Price
$23.95
Total Value
$8.53K
Shares Held After
8,183
% of Holdings
4.4%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
3,329
Price
$23.28
Total Value
$77.50K
Shares Held After
7,827
% of Holdings
42.5%
Faeth Therapeutics, Inc. (FTH)
STEPHENSON BRIAN C — Chief Financial Officer
Shares
1,583
Price
$22.40
Total Value
$35.46K
Shares Held After
4,498
% of Holdings
35.2%
Showing 451–500 of 1414 transactions (page 10 of 29)